CRISTINA PAJARILLAGA-ENCELLO: Open Payments
NPI 1417511650 · CORONA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$846 in 35 payments from 15 companies in 2025. Trend: 2023 $432 · 2024 $732 · 2025 $846
Food & beverage: $846
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $216 |
| Amgen Inc. | 8 | $137 |
| Vanda Pharmaceuticals Inc. | 1 | $119 |
| AstraZeneca Pharmaceuticals LP | 3 | $67 |
| Corcept Therapeutics | 2 | $55 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Lilly USA, LLC | 1 | $30 |
| Exact Sciences Corporation | 1 | $28 |
| Janssen Pharmaceuticals, Inc | 1 | $28 |
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
Products named: VRAYLAR, FANAPT, OTEZLA, Korlym, Auvelity, BREZTRI, MOUNJARO, Cologuard Collection Kit.
Industry payments across CA — which companies pay providers there.
